The efficacy of amoxicillin/potassium clavulanate in treatment of respiratory infection
Zhu Ai-dong
Abstract
Zhu Ai-dong
Abstract
Objective: To evaluate the efficacy of amoxicillin/potassium clavulanate in control of respiratory infection. Methods: This was a single-blind, randomized control trial. Ninety-four patients with respiratory infection were randomly divided into experiment group and control group. Results: Between experiment group and control group, the effective rate was 89.58% and 89.13% respectively, the bacterial clearance rate was 95.00% and 89.13% respectively, side-effect rate was 8.3% and 6.52% respectively. Conclusion: Amoxicillin/potassium clavulanate is effective and well tolerated in the treatment of respiratory infection.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To evaluate the efficacy of amoxicillin/potassium clavulanate in control of respiratory infection. Methods: This was a single-blind, randomized control trial. Ninety-four patients with respiratory infection were randomly divided into experiment group and control group. Results: Between experiment group and control group, the effective rate was 89.58% and 89.13% respectively, the bacterial clearance rate was 95.00% and 89.13% respectively, side-effect rate was 8.3% and 6.52% respectively. Conclusion: Amoxicillin/potassium clavulanate is effective and well tolerated in the treatment of respiratory infection.
Key concepts: Medicine, Amoxicillin, Respiratory system, Internal medicine, Randomized controlled trial, Respiratory infection, Potassium, Gastroenterology